In the past months, systematically higher levels of severe COVID-19 illness and death among individuals belonging to migrant or ethnic minority groups have been reported in several countries, including the USA, the UK, Sweden, Brazil, Spain and South Africa. In particular, racialized populations tend to have less access to testing, higher rates of severe disease, higher mortality rates and worse sequalae when they survive the infection [1 e5]. The interacting social, behavioural and biological pathways underlying these disparities are doubtlessly complex, but the hierarchy of social advantage in racialized societies drives health status, exposure, housing, employment and access to healthcare, and undoubtedly plays the dominant role [6]. Yet, with the notable exception of the UK, European countries do not report COVID-19 statistics according to migrant status or ethnicity (ie individuals' country of origin, nationality or …